Current Industry Perspectives on Monitoring of Protein Aggregation in Biopharmaceuticals

April 9, 2014
11 a.m. to 12:30 pm EST


Sponsored by

Symposium Course Description:

Join us for a panel discussion on current approaches used to detect and monitor protein aggregates using MFI throughout the product development and commercialization process for therapeutic proteins and peptides. During the discussion, industry experts will review analytical methods and discuss how data on protein aggregation is being used in regulatory submissions of biopharmaceuticals.


Lillian Li

Associate Scientist in Formulation Stability Platform

Sanofi Pasteur

Mario Hubert, Ph.D.

Principal Scientist

Bristol Myers Squibb

Zahir Akhunzada, Ph. D.

Research Scientist, PPD

Analytical & Bioanalytical, Bristol-Myers Squibb

Amber Fradkin, Ph.D.



Topics include:

  • Use of MFI imaging-based technology for characterization of sub-visible particles, and sensitive detection of protein aggregates at >2 microns
  • Monitoring biopharmaceutical quality and safety using sub-visible particle analysis with MFI
  • Immunogenicity concerns relating to protein aggregates
  • Control strategy for protein aggregation using MFI in biopharmaceuticals and vaccines

Cost: No cost!

Schedule conflict? Register and you'll receive a copy of the recording!

Download Webinar  

By Series:
By Region: